论文信息 - Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd - 字舞流文

Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd

Y. Kanda | T. Nagai | M. Kurokawa | C. Nakaseko | A. Matsuda | T. Fukuda | Y. Maeda | K. Ohnishi | H. Shibayama | M. Yanada | H. Nakamae | Taro Amagasaki